After launching a public awareness campaign, and great efforts to make monoclonal antibody treatments available locally, over 125 high risk people who are COVID positive in our community have been successfully treated and some likely avoided hospitalization.  There have been others in our community that chose to wait after learning they tested positive because “they were not feeling too badly” or “wanted to wait and see how they will feel in a few days” and are in a more serious condition today as they did not take the antibodies.   We must get the word out clearly that if you fit the criteria in the accompanying letter for receiving this treatment you MUST NOT WAIT after getting a positive Covid test--even if you are feeling fine. This treatment has thus far demonstrated to be very effective but MUST be administered right after a Covid positive test--whether or not you have any symptoms.  If you are in ANY of the high risk categories listed in the antibody criteria you must contact one of your Doctors or Patient Advocates ASAP in order to efficiently be guided through the process.


This treatment is not a cure and should not be thought of as an alternative to protecting yourself from getting infected in the first place. Continue to take all measures to avoid infection including masking, avoiding gatherings, continue social distancing and hand washing. If you, nonetheless, contract Covid you should ACT IMMEDIATELY by following the guidance on the accompanying letter in conjunction with your Doctor’s advice. Monoclonal Antibody treatment is allowed to be given under an Emergency Use Authorization (EUA) granted by the FDA only in the first few days after diagnosis and is proving, so far, to be very effective. After that early window closes, its use is no longer allowed since it is not effective, and you will not be able to receive it.


This therapy is outpatient, the side effects in the experience of the medical centers are minimal if any, and the treatment is standardized; so it can be accessed wherever is easiest and fastest to get an appointment.

If you test COVID positive and meet the criteria below, it is urgent that you obtain an antibody infusion as soon as possible after your positive test.  


Please contact one of the community patient advocates listed in this memo if you meet the FDA criteria outlined below so that they can work with your doctor and schedule you for the outpatient infusion.  


Our  community patient advocates are keeping tabs on where the antibodies are available and how best to schedule you in for a slot.  The infusion process is short and you should be back home in a few hours. 


It is best to get these antibodies as soon as possible after receiving a COVID positive PCR test result. Once you receive the antibodies, please continue to practice social distancing and masking as you can still spread the virus to others. 


If you are not currently infected, please continue to avoid getting infected with COVID; It is critical to implement proper distancing, masking, etc.  There is no guarantee that any particular treatment will help an individual.  This is a challenging period as many people in the community have been infected.   Keep yourself and your family safe. 


If you receive the antibody treatment, you should wait 90 days and consult with your doctor before getting vaccinated.


Dr. Albert Bassoul, MD 

Alan Esses, Hatzalah

Dr. Albert Ftiha, MD

Dr. Victor Grazi, MD, Mt Sinai

Dr. David Khaski, MD, NYU

Dr. Ralph Madeb, MD, NYCH

Dr. Daniel Matalon, MD, NYU

Dr. Stanley Schrem, MD, NYU

Patient advocates


Baruch Sandhaus



Mark Massry



Alan Esses



Nathan Hoffman



Gershon Fink, MD



Dr. Ralph Madeb



Nancy Sutton



Maurice Zekaria



Ike D Massry



Dr. Ralph Madeb



Medical Centers offering Monoclonal Antibodies for Outpatient Infusion 



Aventura Hospital


Monmouth Medical Center


Mount Sinai


Memorial Hospital


HNMC, Teaneck


New York Community Hospital


Mt Sinai of Miami Beach


Maimonidies Hospital


FDA Inclusion Criteria

The antibody treatments are for high risk patients.  High risk is defined as patients who meet at least one​ of the following criteria:  


  • ​65 years of age or older

  • Adult who is obese or has a BMI greater than 25

  • Child who has a BMI greater than 85th percentile

  • Patient who has cancer or are in remission of cancer

  • Pregnant or 12 weeks postpartum

  • Chronic kidney or lung disease including asthma

  • Diabetes, High blood pressure & any cardiovascular diseases

  • Sickle cell disease

  • Neurodevelopmental disorders

  • Immunocompromised or taking immunocompromising medication

  • Medical-related technological dependence such as tracheostomy or gastrostomy












This communication is provided for informational purposes only and does not constitute the provision of medical advice. The information is being made available in the context of the public health emergency related to COVID-19, has been obtained from publicly available sources, and has not been subjected to review or investigation that typically would be performed in a non-emergent situation. This information is not meant to be complete, exhaustive, or a substitute for medical professional advice, diagnosis, or treatment and should be adapted to a patient’s specific needs, available resources, and any other unique circumstances. Neither the Sephardic Community Alliance, nor any contributor to this communication, makes any representations or warranties, express or implied, with respect to the information provided herein or to its use..